本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mereo Biopharma Group Plc

2.50
+0.17007.30%
成交量:235.60万
成交额:583.87万
市值:3.98亿
市盈率:-8.55
高:2.55
开:2.36
低:2.33
收:2.33
数据加载中...
2021/12/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/29

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/07

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/01

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/10/20

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/29

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/09

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]